Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

Feb 06: CMS Has Paid More Than $19B in Meaningful Use Payments

care coordination software

As of the end of December 2013, CMS had doled out more than $19 billion in incentive payments to eligible hospitals and health care providers participating in the meaningful use program, Government Health IT reports.

Under the 2009 federal economic stimulus package, health care providers who demonstrate meaningful use of certified electronic health record systems can qualify for Medicaid and Medicare incentive payments.

Details of Payments

During a Health IT Policy Committee meeting, CMS announced that nearly 441,000 eligible hospitals and professionals had registered for meaningful use as the end of December 2013.

Robert Anthony, deputy director at CMS’ Office of E-Health Standards and Services, said that as of the end of year:

  • 90% of eligible hospitals had made a financial commitment to an EHR;
  • 63% of Medicare- and Medicaid-eligible professionals had financially committed to an EHR;
  • 88% of eligible hospitals had received an EHR incentive payment; and
  • 78% of Medicaid-eligible professionals had received an EHR incentive payment.

CMS also noted that about:

  • 60% of Medicare-eligible professionals were meaningful users of EHRs; and
  • 20% of Medicaid-eligible professionals were meaningful users.

Meanwhile, CMS also released the results of the 2013 National Electronic Health Records Survey, which found that 19% of physicians who plan to participate in the meaningful use program had adopted 14 of 17 meaningful use Stage 2 objectives (Manos, Government Health IT, 2/4).

Stakeholders Raiser Concerns

In related news, at the Health IT Policy Committee’s meaningful use workgroup meeting, stakeholders raised concerns about the program’s complexity and rigidity, Modern Healthcare reports.

They noted that vendors have been slow to test and certify their EHR systems for Stage 2 of the meaningful use program, which has delayed health care providers’ implementation. As a result, providers are pushing for more flexibility.

Mari Savickis, director of federal affairs for the American Medical Association, said, “[S]ome [of] our physicians are still in Stage 1,” adding, “Without flexibility, some of them will be dropping out” of the program.

Similarly, Mark Segal, vice president of government and industry affairs for GE Healthcare, said that the focus of Stage 3 “should be on greater use of Stage 2 capabilities” rather than developing even stricter regulations.

The stakeholders suggested that the workgroup fix such issues with Stage 2 of the meaningful use program before issuing additional regulations for Stage 3 criteria (Conn, Modern Healthcare, 2/4). Source